Distinct Transcriptional Programs Control Cross-Priming in Classical and Monocyte-Derived Dendritic Cells

Cell Reports

Volumn 15, Issue 11, 2016, Pages 2462-2474

  Briseño, Carlos G ^a   Haldar, Malay ^b   Kretzer, Nicole M ^a   Wu, Xiaodi ^a   Theisen, Derek J ^a   Wumesh, K C ^a   Durai, Vivek ^a   Grajales Reyes, Gary E ^a   Iwata, Arifumi ^a   Bagadia, Prachi ^a   Murphy, Theresa L ^a   Murphy, Kenneth M ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BATF3 PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 4; MEMBRANE RECEPTOR; NUCLEAR RECEPTOR NUR77; TRANSCRIPTION FACTOR; TREML4 PROTEIN; UNCLASSIFIED DRUG; ANTIGEN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; IMMUNOGLOBULIN RECEPTOR; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; NR4A1 PROTEIN, MOUSE; REPRESSOR PROTEIN; SNFT PROTEIN, MOUSE; TREML4 PROTEIN, MOUSE;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; FEMALE; GENE EXPRESSION; MALE; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL LINEAGE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; CROSS-PRIMING; DENDRITIC CELLS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON REGULATORY FACTORS; INTERLEUKIN-4; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; RECEPTORS, IMMUNOLOGIC; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84974715217     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.05.025     Document Type: Article

References (75)

1. Aldridge J.R., Moseley C.E., Boltz D.A., Negovetich N.J., Reynolds C., Franks J., Brown S.A., Doherty P.C., Webster R.G., Thomas P.G. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl. Acad. Sci. USA 2009, 106:5306-5311.
2. Auffray C., Fogg D.K., Narni-Mancinelli E., Senechal B., Trouillet C., Saederup N., Leemput J., Bigot K., Campisi L., Abitbol M., et al. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J. Exp. Med. 2009, 206:595-606.
3. Bajaña S., Roach K., Turner S., Paul J., Kovats S. IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation. J. Immunol. 2012, 189:3368-3377.
4. Ballesteros-Tato A., León B., Lund F.E., Randall T.D. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat. Immunol. 2010, 11:216-224.
5. Becker M., Güttler S., Bachem A., Hartung E., Mora A., Jäkel A., Hutloff A., Henn V., Mages H.W., Gurka S., Kroczek R.A. Ontogenic, phenotypic, and functional characterization of XCR1(+) dendritic cells leads to a consistent classification of intestinal dendritic cells based on the expression of XCR1 and SIRPα. Front. Immunol. 2014, 5:326.
6. Briseño C.G., Murphy T.L., Murphy K.M. Complementary diversification of dendritic cells and innate lymphoid cells. Curr. Opin. Immunol. 2014, 29:69-78.
7. Carbone F.R., Bevan M.J. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 1990, 171:377-387.
8. Carreno B.M., Magrini V., Becker-Hapak M., Kaabinejadian S., Hundal J., Petti A.A., Ly A., Lie W.R., Hildebrand W.H., Mardis E.R., Linette G.P. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science 2015, 348:803-808.
9. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992, 360:258-261.
10. Cebrian I., Visentin G., Blanchard N., Jouve M., Bobard A., Moita C., Enninga J., Moita L.F., Amigorena S., Savina A. Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells. Cell 2011, 147:1355-1368.
11. Cheong C., Matos I., Choi J.H., Dandamudi D.B., Shrestha E., Longhi M.P., Jeffrey K.L., Anthony R.M., Kluger C., Nchinda G., et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 2010, 143:416-429.
12. den Haan J.M., Lehar S.M., Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 2000, 192:1685-1696.
13. DeYoung R.A., Baker J.C., Cado D., Winoto A. The orphan steroid receptor Nur77 family member Nor-1 is essential for early mouse embryogenesis. J. Biol. Chem. 2003, 278:47104-47109.
14. El Chartouni C., Schwarzfischer L., Rehli M. Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming. Immunobiology 2010, 215:821-825.
15. Firat E., Saveanu L., Aichele P., Staeheli P., Huai J., Gaedicke S., Nil A., Besin G., Kanzler B., van Endert P., Niedermann G. The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. J. Immunol. 2007, 178:2241-2248.
16. Ford J.W., McVicar D.W. TREM and TREM-like receptors in inflammation and disease. Curr. Opin. Immunol. 2009, 21:38-46.
17. Gao Y., Nish S.A., Jiang R., Hou L., Licona-Limón P., Weinstein J.S., Zhao H., Medzhitov R. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 2013, 39:722-732.
18. Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., Helft J., Chow A., Elpek K.G., Gordonov S., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012, 13:1118-1128. Immunological Genome Consortium.
19. Grajales-Reyes G.E., Iwata A., Albring J., Wu X., Tussiwand R., KC W., Kretzer N.M., Briseño C.G., Durai V., Bagadia P., et al. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor. Nat. Immunol. 2015, 16:708-717.
20. Greter M., Helft J., Chow A., Hashimoto D., Mortha A., Agudo-Cantero J., Bogunovic M., Gautier E.L., Miller J., Leboeuf M., et al. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 2012, 36:1031-1046.
21. Guilliams M., Malissen B. A death notice for in-vitro-generated GM-CSF dendritic cells?. Immunity 2015, 42:988-990.
22. Haldar M., Kohyama M., So A.Y., KC W., Wu X., Briseño C.G., Satpathy A.T., Kretzer N.M., Arase H., Rajasekaran N.S., et al. Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell 2014, 156:1223-1234.
23. Hanna R.N., Carlin L.M., Hubbeling H.G., Nackiewicz D., Green A.M., Punt J.A., Geissmann F., Hedrick C.C. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat. Immunol. 2011, 12:778-785.
24. Helft J., Böttcher J., Chakravarty P., Zelenay S., Huotari J., Schraml B.U., Goubau D., Reis e Sousa C. GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c(+)MHCII(+) macrophages and dendritic cells. Immunity 2015, 42:1197-1211.
25. Hemmi H., Zaidi N., Wang B., Matos I., Fiorese C., Lubkin A., Zbytnuik L., Suda K., Zhang K., Noda M., et al. Treml4, an Ig superfamily member, mediates presentation of several antigens to T cells in vivo, including protective immunity to HER2 protein. J. Immunol. 2012, 188:1147-1155.
26. Hildner K., Edelson B.T., Purtha W.E., Diamond M., Matsushita H., Kohyama M., Calderon B., Schraml B.U., Unanue E.R., Diamond M.S., et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008, 322:1097-1100.
27. Höltl L., Rieser C., Papesh C., Ramoner R., Herold M., Klocker H., Radmayr C., Stenzl A., Bartsch G., Thurnher M. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J. Urol. 1999, 161:777-782.
28. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176:1693-1702.
29. Inaba K., Inaba M., Deguchi M., Hagi K., Yasumizu R., Ikehara S., Muramatsu S., Steinman R.M. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. USA 1993, 90:3038-3042.
30. Ishii M., Wen H., Corsa C.A., Liu T., Coelho A.L., Allen R.M., Carson W.F., Cavassani K.A., Li X., Lukacs N.W., et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 2009, 114:3244-3254.
31. + T cells. Nat. Immunol. 2013, 14:254-261.
32. Joffre O.P., Segura E., Savina A., Amigorena S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 2012, 12:557-569.
33. KC W., Satpathy A.T., Rapaport A.S., Briseño C.G., Wu X., Albring J.C., Russler-Germain E.V., Kretzer N.M., Durai V., Persaud S.P., et al. L-Myc expression by dendritic cells is required for optimal T-cell priming. Nature 2014, 507:243-247.
34. Langlet C., Tamoutounour S., Henri S., Luche H., Ardouin L., Grégoire C., Malissen B., Guilliams M. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J. Immunol. 2012, 188:1751-1760.
35. Lehtonen A., Veckman V., Nikula T., Lahesmaa R., Kinnunen L., Matikainen S., Julkunen I. Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages. J. Immunol. 2005, 175:6570-6579.
36. León B., Martínez del Hoyo G., Parrillas V., Vargas H.H., Sánchez-Mateos P., Longo N., López-Bravo M., Ardavín C. Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells. Blood 2004, 103:2668-2676.
37. León B., López-Bravo M., Ardavín C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007, 26:519-531.
38. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., Demay M.B. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 1997, 94:9831-9835.
39. Linette G.P., Carreno B.M. Dendritic cell-based vaccines: shining the spotlight on signal 3. OncoImmunology 2013, 2:e26512.
40. Liu K., Waskow C., Liu X., Yao K., Hoh J., Nussenzweig M. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 2007, 8:578-583.
41. Lybarger L., Yu Y.Y., Miley M.J., Fremont D.H., Myers N., Primeau T., Truscott S.M., Connolly J.M., Hansen T.H. Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide. J. Biol. Chem. 2003, 278:27105-27111.
42. Martínez-González J., Badimon L. The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. Cardiovasc. Res. 2005, 65:609-618.
43. Matheoud D., Moradin N., Bellemare-Pelletier A., Shio M.T., Hong W.J., Olivier M., Gagnon E., Desjardins M., Descoteaux A. Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8. Cell Host Microbe 2013, 14:15-25.
44. Meredith M.M., Liu K., Darrasse-Jeze G., Kamphorst A.O., Schreiber H.A., Guermonprez P., Idoyaga J., Cheong C., Yao K.H., Niec R.E., Nussenzweig M.C. Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J. Exp. Med. 2012, 209:1153-1165.
45. Miller J.C., Brown B.D., Shay T., Gautier E.L., Jojic V., Cohain A., Pandey G., Leboeuf M., Elpek K.G., Helft J., et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 2012, 13:888-899. Immunological Genome Consortium.
46. Moran A.E., Holzapfel K.L., Xing Y., Cunningham N.R., Maltzman J.S., Punt J., Hogquist K.A. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 2011, 208:1279-1289.
47. Naik S.H., Sathe P., Park H.Y., Metcalf D., Proietto A.I., Dakic A., Carotta S., O'Keeffe M., Bahlo M., Papenfuss A., et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat. Immunol. 2007, 8:1217-1226.
48. Nair-Gupta P., Baccarini A., Tung N., Seyffer F., Florey O., Huang Y., Banerjee M., Overholtzer M., Roche P.A., Tampé R., et al. TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation. Cell 2014, 158:506-521.
49. Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 1998, 4:328-332.
50. Nierkens S., Tel J., Janssen E., Adema G.J. Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?. Trends Immunol. 2013, 34:361-370.
51. Nowyhed H.N., Huynh T.R., Thomas G.D., Blatchley A., Hedrick C.C. Cutting edge: the orphan nuclear receptor Nr4a1 regulates CD8+ T cell expansion and effector function through direct repression of Irf4. J. Immunol. 2015, 195:3515-3519.
52. Palucka K., Banchereau J. Dendritic-cell-based therapeutic cancer vaccines. Immunity 2013, 39:38-48.
53. Persson E.K., Uronen-Hansson H., Semmrich M., Rivollier A., Hägerbrand K., Marsal J., Gudjonsson S., Håkansson U., Reizis B., Kotarsky K., Agace W.W. IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 2013, 38:958-969.
54. Qiu P., Simonds E.F., Bendall S.C., Gibbs K.D., Bruggner R.V., Linderman M.D., Sachs K., Nolan G.P., Plevritis S.K. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat. Biotechnol. 2011, 29:886-891.
55. Ramirez-Ortiz Z.G., Prasad A., Griffith J.W., Pendergraft W.F., Cowley G.S., Root D.E., Tai M., Luster A.D., El Khoury J., Hacohen N., Means T.K. The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity. Nat. Immunol. 2015, 16:495-504.
56. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994, 180:83-93.
57. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994, 179:1109-1118.
58. Satoh T., Takeuchi O., Vandenbon A., Yasuda K., Tanaka Y., Kumagai Y., Miyake T., Matsushita K., Okazaki T., Saitoh T., et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 2010, 11:936-944.
59. Satpathy A.T., KC W., Albring J.C., Edelson B.T., Kretzer N.M., Bhattacharya D., Murphy T.L., Murphy K.M. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J. Exp. Med. 2012, 209:1135-1152.
60. Satpathy A.T., Wu X., Albring J.C., Murphy K.M. Re(de)fining the dendritic cell lineage. Nat. Immunol. 2012, 13:1145-1154.
61. Saveanu L., Carroll O., Weimershaus M., Guermonprez P., Firat E., Lindo V., Greer F., Davoust J., Kratzer R., Keller S.R., et al. IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science 2009, 325:213-217.
62. Savina A., Jancic C., Hugues S., Guermonprez P., Vargas P., Moura I.C., Lennon-Duménil A.M., Seabra M.C., Raposo G., Amigorena S. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 2006, 126:205-218.
63. Savina A., Peres A., Cebrian I., Carmo N., Moita C., Hacohen N., Moita L.F., Amigorena S. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells. Immunity 2009, 30:544-555.
64. Schlitzer A., McGovern N., Teo P., Zelante T., Atarashi K., Low D., Ho A.W., See P., Shin A., Wasan P.S., et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 2013, 38:970-983.
65. Segura E., Amigorena S. Cross-presentation in mouse and human dendritic cells. Adv. Immunol. 2015, 127:1-31.
66. Segura E., Albiston A.L., Wicks I.P., Chai S.Y., Villadangos J.A. Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proc. Natl. Acad. Sci. USA 2009, 106:20377-20381.
67. Suzuki S., Honma K., Matsuyama T., Suzuki K., Toriyama K., Akitoyo I., Yamamoto K., Suematsu T., Nakamura M., Yui K., Kumatori A. Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development. Proc. Natl. Acad. Sci. USA 2004, 101:8981-8986.
68. Thurner B., Haendle I., Röder C., Dieckmann D., Keikavoussi P., Jonuleit H., Bender A., Maczek C., Schreiner D., von den Driesch P., et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 1999, 190:1669-1678.
69. Timmerman J.M., Czerwinski D.K., Davis T.A., Hsu F.J., Benike C., Hao Z.M., Taidi B., Rajapaksa R., Caspar C.B., Okada C.Y., et al. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood 2002, 99:1517-1526.
70. Torti N., Walton S.M., Murphy K.M., Oxenius A. Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation. Eur. J. Immunol. 2011, 41:2612-2618.
71. Tussiwand R., Lee W.L., Murphy T.L., Mashayekhi M., KC W., Albring J.C., Satpathy A.T., Rotondo J.A., Edelson B.T., Kretzer N.M., et al. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 2012, 490:502-507.
72. Vander Lugt B., Khan A.A., Hackney J.A., Agrawal S., Lesch J., Zhou M., Lee W.P., Park S., Xu M., DeVoss J., et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat. Immunol. 2014, 15:161-167.
73. Williams J.W., Tjota M.Y., Clay B.S., Vander Lugt B., Bandukwala H.S., Hrusch C.L., Decker D.C., Blaine K.M., Fixsen B.R., Singh H., et al. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nat. Commun. 2013, 4:2990.
74. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., Kawakami T., Arioka K., Sato H., Uchiyama Y., et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 1997, 16:391-396.
75. Zou L., Zhou J., Zhang J., Li J., Liu N., Chai L., Li N., Liu T., Li L., Xie Z., et al. The GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cells. Proc. Natl. Acad. Sci. USA 2009, 106:15801-15806.